Skip to main content
Clinical Trials/EUCTR2013-003220-36-NL
EUCTR2013-003220-36-NL
Active, not recruiting
Phase 1

Remifentanil use for procedural sedation and analgesia in the emergency department

Albert Schweitzer hospital0 sitesJanuary 15, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Albert Schweitzer hospital
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 15, 2014
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All the patients who need procedural sedation and analgesia (PSA) at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra\-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, allergy for fentanyl propofol remifentanil soy or chicken proteins.

Outcomes

Primary Outcomes

Not specified

Similar Trials